Theriva Biologics (TOVX) Stock: Buy, Sell, or Hold?
$0.16
+0.01 (+4.35%)
▲
5d:
-15.32%
30d:
-25.41%
90d:
-30.04%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$0.17 – $0.22
Position: OVERSOLD
Forward P/E & Valuation
-0.8x
Next 12M consensus est.
Wall Street Target
$4.00
+2386.0% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.14 / $0.20
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: TOVX is down 15.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When TOVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TOVX is currently trading at $0.16, which is considered oversold relative to its 30-day fair value range of $0.17 to $0.22.
Technical Outlook: Technically, TOVX is in a downtrend. Immediate support is located at $0.14, while resistance sits at $0.20. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+2386.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TOVX is in a downtrend. Immediate support is located at $0.14, while resistance sits at $0.20. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+2386.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.17 -
$0.22
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$0.17 -
$0.22
Current vs Trading Range
OVERSOLD
Support Level
$0.14
Resistance Level
$0.20
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 2386.0% below Wall St target ($4.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.80
Wall Street Target
$4.00
(+2386.0%)
Share TOVX Analysis
Share this live TOVX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TOVX)
Bullish
7 Retail Mentions
Reddit / WSB Comments
5
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages express bullish sentiment towards $TOVX, with traders focusing on the potential success of the company's non-oncology pipelines and the appeal of royalty deals.
Key Retail Themes:
Potential success of non-oncology pipelines
Appeal of royalty deals
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:24 PM ET
Data refreshes hourly during market hours. Next update: 10:24 PM
Data refreshes hourly during market hours. Next update: 10:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TOVX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TOVX Research Pages